| abstract |
The present invention relates to pharmaceutical compositions comprising ( E )-4-(2- (aminomethyl)-3-fluoroallyloxy)- N-tert -butylbenzamide having chemical structure (I) or a pharmaceutically acceptable salt thereof as active pharmaceutical ingredient, particularly to pharmaceutical compositions comprising ( E )-4-(2-(aminomethyl)-3-fluoroallyloxy)- N -ter t -butylbenzamide hydrochloride, to pharmaceutical dosage forms, to their preparation, their use and methods for therapeutic treatment. |